Form 8-K - Current report:
SEC Accession No. 0001607062-22-000724
Filing Date
2022-11-21
Accepted
2022-11-21 17:11:06
Documents
12
Period of Report
2022-11-18
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K rgbp112122form8k.htm   iXBRL 8-K 21741
  Complete submission text file 0001607062-22-000724.txt   190004

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE rgbp-20221111.xsd EX-101.SCH 3254
3 XBRL LABEL FILE rgbp-20221111_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE rgbp-20221111_pre.xml EX-101.PRE 22377
6 EXTRACTED XBRL INSTANCE DOCUMENT rgbp112122form8k_htm.xml XML 3398
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

EIN.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 221406651
SIC: 2834 Pharmaceutical Preparations